Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 99

Results For "CHEMI"

1044 News Found

Covid-19 severity screening method developed
Digitisation | August 23, 2021

Covid-19 severity screening method developed

Researchers from IIT Bombay and QIMR Berghofer Medical Research Institute, Australia have developed this method, based on the Agilent Cary 630 FTIR Spectrometer


Sai Life Sciences opens discovery biology facility in Hyderabad
Drug Approval | August 19, 2021

Sai Life Sciences opens discovery biology facility in Hyderabad

The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others


EpiEndo Pharma secures  EUR 20 Million Series A funding for Macrolide
Biotech | August 18, 2021

EpiEndo Pharma secures EUR 20 Million Series A funding for Macrolide

The financing secures funds to advance the clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication


India should focus on pharma intermediates self-sufficiency : A column by Dr. K. Nagaiah,Chief Scientist & Head - Centre for Natural Product and Traditional Knowledge, CSIR-IICT, Hyderabad
interviews | August 17, 2021

India should focus on pharma intermediates self-sufficiency : A column by Dr. K. Nagaiah,Chief Scientist & Head - Centre for Natural Product and Traditional Knowledge, CSIR-IICT, Hyderabad

India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers


Manjushree Technopack set to acquire Classy Kontainers
Packaging | August 17, 2021

Manjushree Technopack set to acquire Classy Kontainers

MTL, with over 40 years of experience in packaging, caters to the requirements of the FMCG, F&B, homecare, personal care, agrochemicals, pharmaceutical, and liquor industries


Suven Life Sciences announces Phase 3 clinical trial of Masupirdine
Biotech | August 17, 2021

Suven Life Sciences announces Phase 3 clinical trial of Masupirdine

This multi-centre study (sites in the US and Europe) comprising about 387 patients is likely to be completed in about 36 months and the topline result is expected by the end of 2024


Antiviral face mask capable of inactivating COVID19
News | August 16, 2021

Antiviral face mask capable of inactivating COVID19

The antiviral technology involves the presence of active positive charges on the fabric, as binding sites for viruses and on contact with the fabric, virus cells that are negatively charged are neutralised, leading to the rapid destruction of their glycoprotein layers and the release of non-infectious ribonucleic acid (RNA)


Syngene sets up microbial facility as it expands biopharma-manufacturing capacity
Biotech | August 13, 2021

Syngene sets up microbial facility as it expands biopharma-manufacturing capacity

It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies


New CAP guideline improves diagnoses of patients with Monoclonal Gammopathies
Healthcare | August 11, 2021

New CAP guideline improves diagnoses of patients with Monoclonal Gammopathies

The American Association for Clinical Chemistry (AACC); the American Society for Clinical Pathology (ASCP); the American Society of Hematology (ASH); and the International Myeloma Working Group (IMWG), collaborate to develop the guideline


NPPA has put a cap on the trade margin of 42 select non-scheduled anti-cancer medicines
Policy | August 11, 2021

NPPA has put a cap on the trade margin of 42 select non-scheduled anti-cancer medicines

A total of 526 brands has seen a reduction of up to 90 per cent in MRP